콘텐츠로 건너뛰기
  • SOLUTIONS
    • Drug Discovery Sevices
    • Collaboration Partners
    • Platform
  • R&D
    • Platform Technology
    • Pipelines
    • Publications
    • Patent & Cert.
  • ABOUT US
    • Overview
    • History
    • Partnership
    • CI & BI
  • NEWS
    • Press Release
    • Seminars & Events
    • Notice
    • Responsibility
  • CAREER
Menu
  • SOLUTIONS
    • Drug Discovery Sevices
    • Collaboration Partners
    • Platform
  • R&D
    • Platform Technology
    • Pipelines
    • Publications
    • Patent & Cert.
  • ABOUT US
    • Overview
    • History
    • Partnership
    • CI & BI
  • NEWS
    • Press Release
    • Seminars & Events
    • Notice
    • Responsibility
  • CAREER
Get In Touch

Press Release

HOME > NEWS > Press Release​

PharmCADD signed MOU with Qunova to develop new drug utilizing Quantum Computing.

READ MORE

“PharmCADD will be the first case to commercialize AI-generated COVID19 vaccine.”, said CEO.

READ MORE

PharmCADD is growing to be a global company.

READ MORE

PharmCADD participated in 2022 Global IR @JPM Virtual Demo Day.

READ MORE

“The first AI-based mRNA vaccine will be launched into the world in 2022.” said PharmCADD CEO.

READ MORE

AI-based drug development is becoming a game changer.

READ MORE

PharmCADD participated the special donation activity of Salvation Army

READ MORE

PharmCADD will open Pharmulator ver. 2.5 and PharmVAC, AI-based drug discovery platforms during CES 2022.

READ MORE

The love of neighbors from PharmCADD

READ MORE
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Next »
Headquarters

Address : 224, Engineering Building 7, Sinseon-Ro 365, Namgu, Busan 48548, Republic of Korea
Call : 82-51-747-5681 | Fax : 82-51-747-5682

Seoul Office

Address : 1735, 280, Gwangpyeong-ro, Gangnam-gu, Seoul, Republic of Korea
Call : 82-2-564-5688 | Fax : 82-2-564-5685

E-Mail : [email protected]
Call : 82-51-747-5681
Linkedin-in Youtube

© 2021 PharmCADD. All Rights Reserved.